DCM
MDT icon

DGS Capital Management’s Medtronic MDT Stock Holding History

DGS Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$9.61K – 677
2025
Q4 		$9.61K Buy
+100
New +$9.71K ﹤0.01% 540

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DGS Capital Management's MDT Position: Q1 2026 in Review

DGS Capital Management reduced its Medtronic (MDT) stake by 20% in Q1 2026, selling an estimated $172K and leaving 7,232 shares worth $627K. The position accounts for 0.1% of the portfolio, ranked #190.

DGS Capital Management first reported a position in MDT in Q4 2021 and has held it in 17 quarters since. The position peaked at $975K in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • DGS Capital Management held 7,232 shares of Medtronic worth $627K as of Q1 2026.
  • DGS Capital Management sold 1,792 Medtronic shares in Q1 2026, an estimated $172K.
  • Medtronic made up 0.1% of DGS Capital Management's portfolio in Q1 2026, its #190 holding.
  • DGS Capital Management first reported a position in Medtronic in Q4 2021 and has held it in 17 quarters since.
  • DGS Capital Management's Medtronic position peaked at $975K in Q3 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on DGS Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.